IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 17,480
+380 (2.22%)
At close: Sep 23, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 262.58 billion as of September 25, 2026. Its market cap has decreased by -55.40% in one year.
Market Cap
262.58B
Enterprise Value
248.88B
Revenue
3.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,480.00
ChartMarket Cap Chart
Since May 23, 2025, IntoCell's market cap has decreased from 492.33B to 262.58B, a decrease of -46.66%. That is a compound annual growth rate of -37.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 262.58B | -69.50% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 326.04B |
| Curocell | 322.82B |
| IMBiologics | 262.16B |
| HansBiomed | 253.57B |
| Genome & Company | 252.87B |
| S.Biomedics | 249.56B |
| curacle co.,ltd. | 212.04B |
| Kangstem Biotech | 193.75B |